Leerink downgraded Accolade (ACCD) to Market Perform from Outperform with a price target of $7.03, down from $9.50, after the company agreed to an acquisition by Transcarent. The firm views the deal as “logical both operationally and strategically,” the analyst tells investors.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ACCD:
- Accolade downgraded to Market Perform from Outperform at William Blair
- Accolade Acquired by Transcarent in Strategic Merger
- Accolade trading resumes
- Accolade to be acquired by Transcarent for $7.03 per share
- Accolade to be acquired by Transcarent for $7.03 per share in cash
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
